Health Atlas
Menu
Evidence-led reference

Prevention & care

Common cold: viral causes, overlapping symptoms, recovery, medicines, and antibiotic evidence

6 sources · Latest source check 2026-10-13 UTC
On this page

A common cold is a viral infection of the upper respiratory tract, mainly the nose and throat. Many viruses can cause it, especially rhinoviruses. “Cold-like” symptoms are nonspecific: influenza, COVID-19 and other respiratory illnesses can resemble a cold but have different risks and treatments.[1]

A symptom label is not a pathogen result

A symptom label is not a pathogen result
TermMeaning
RhinovirusA frequent cause of common colds.[1]
Upper respiratory infectionA location-based illness label, not one particular virus.[1]
Purulent rhinitisColored nasal discharge; color alone does not establish an antibiotic benefit.[5]

A familiar pattern can overlap with a more consequential infection

A runny or blocked nose, sneezing, sore throat and cough are typical. Symptoms often develop gradually. A high-risk person with cold-like illness may need prompt assessment for influenza or COVID-19, because those infections have separate treatment pathways. A symptom comparison table cannot reliably identify the virus in every individual.[1]

Different summaries describe different recovery windows

CDC says colds usually last less than a week; NHS says people generally start feeling better within one to two weeks, with longer symptoms in some children. These summaries do not define a single deadline for every symptom. Worsening, recurrence or persistent symptoms can call for reassessment rather than a duration-based home diagnosis.[1][3]

Temporary comfort and a proven cure are different claims

CDC describes rest, fluids and appropriate symptom-relief options. Over-the-counter medicines may ease pain, fever or congestion but do not cure the illness. A pharmacist or clinician can check suitability and other medicines. A supplement claim should identify prevention versus treatment after onset, formulation and measured outcome; the linked nutrient pages examine those narrower questions.[2]

Combination products can duplicate ingredients

FDA warns that several cough/cold products can contain the same active drug, creating accidental overdose risk. Adult products are not automatically suitable for children. US safety warnings for particular ingredients in children under two, manufacturers’ under-four labels and CDC’s broader under-six advice are different policy thresholds, rather than interchangeable dosing instructions.[4][2]

Household remedies also have age and injury limits

NHS warns against honey in infants under twelve months and against children breathing steam from bowls of hot water because of scalding risk. Natural or familiar does not mean suitable at every age. The page does not supply child-specific quantities or substitute a homemade treatment for assessment of breathing or feeding difficulty.[3]

A cold label should not hide worsening illness

NHS advises assessment for worsening illness, breathing difficulty, chest pain or prolonged symptoms, and for concerning illness in people with long-term conditions or immune suppression. Local urgent-care guidance applies to severe symptoms. A reader cannot use an apparently mild label to rule out a complication.[3]

A familiar active ingredient can have weak efficacy evidence

FDA’s inspected information describes proposed removal of oral phenylephrine as a nasal-decongestant ingredient because evidence does not support its effectiveness for that purpose. The proposal concerns the oral route, not every nasal product, and efficacy differs from ingredient duplication or overdose risk. Being sold in a familiar combination medicine is not independent evidence that each ingredient relieves its advertised symptom.[6]

Evidence & uncertainty

Most colds improve without a specific cure. Symptom relief is different from eliminating the virus, and antibiotics do not treat an uncomplicated viral cold. Drug ingredients, age and other conditions matter. An older antibiotic review supports this distinction but does not settle every illness labeled a cold.[2][5]

Selected-source overview · Independent review pending

Published questions

Is the common cold caused by one specific virus?

Selected-source overview · Independent review pending. Read the evidence context.

Many viruses cause colds; rhinoviruses are frequent causes.[1]

Evidence behind this answer
  • About Common Cold

    agency condition or prevention explanation · 2026
    Selected relevant original official page passages inspected · Viral causes, cold-like illness and typical course

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Do cold-like symptoms reliably exclude influenza or COVID-19?

Selected-source overview · Independent review pending. Read the evidence context.

Different infections overlap in symptoms and can require different care.[1]

Evidence behind this answer
  • About Common Cold

    agency condition or prevention explanation · 2026
    Selected relevant original official page passages inspected · Viral causes, cold-like illness and typical course

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Is one week an exact recovery deadline for every cold?

Selected-source overview · Independent review pending. Read the evidence context.

Agency summaries describe typical courses, not a guarantee for every symptom.[3]

Evidence behind this answer
  • Common cold

    agency condition or prevention explanation · Date not stated
    Selected relevant original official page passages inspected · Recovery range, honey/steam limits and assessment contexts

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Do common-cold medicines cure the viral infection?

Selected-source overview · Independent review pending. Read the evidence context.

They can provide symptom relief without curing the infection.[2]

Evidence behind this answer
  • Manage Common Cold

    agency condition or prevention explanation · 2026
    Selected relevant original official page passages inspected · Relief versus cure, pediatric policy and bacterial complications

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does colored nasal mucus automatically mean antibiotics will help?

Selected-source overview · Independent review pending. Read the evidence context.

The inspected review did not establish benefit for short-duration purulent rhinitis.[5]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a newer cold-review listing prove a newly updated evidence search?

Selected-source overview · Independent review pending. Read the evidence context.

The inspected page still displays a February 2013 search method.[5]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can using several cold products duplicate the same active drug?

Selected-source overview · Independent review pending. Read the evidence context.

Combination products can overlap and lead to accidental overdose.[4]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Is honey a suitable cold remedy for every infant?

Selected-source overview · Independent review pending. Read the evidence context.

NHS advises against honey under twelve months.[3]

Evidence behind this answer
  • Common cold

    agency condition or prevention explanation · Date not stated
    Selected relevant original official page passages inspected · Recovery range, honey/steam limits and assessment contexts

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does the oral-phenylephrine proposal apply automatically to all nasal decongestants?

Selected-source overview · Independent review pending. Read the evidence context.

It concerns a particular ingredient, route and intended use.[6]

Evidence behind this answer
  • Key Information About OTC Oral Phenylephrine

    agency medicine explanation · Date not stated
    Indexed original abstract or official-page passages inspected in search; full-page access not established · Efficacy-based proposed removal and oral-versus-nasal scope

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Antibiotic trials do not support routine treatment of a cold

The inspected Cochrane review compared antibiotics with placebo for common-cold symptoms and short-duration colored nasal discharge. Its summary found no meaningful benefit for these conditions and described adverse effects. Some included studies had diagnostic and other flaws, which limit how precisely the pooled findings apply.[5]

The newer listing date is not proof of a new literature search: displayed methods still describe searches through February 2013. That limitation matters when assessing how current the review is.[5]

Bacterial complications, such as pneumonia, need separate assessment. Cold evidence does not negate treatment for a different established bacterial infection.[2]

References

  1. About Common Cold

    Agency condition or prevention explanation

    CDC · Content/publication date: 2026
    Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
    Cited sections: Viral causes, cold-like illness and typical course

    Dated 19 February 2026; symptoms are not a confirmed pathogen.

  2. Manage Common Cold

    Agency condition or prevention explanation

    CDC · Content/publication date: 2026
    Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
    Cited sections: Relief versus cure, pediatric policy and bacterial complications

    Dated 11 March 2026; no individual medicine selection.

  3. Common cold

    Agency condition or prevention explanation

    NHS · Content/publication date: not stated
    Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
    Cited sections: Recovery range, honey/steam limits and assessment contexts

    Different typical duration wording is made explicit.

  4. Use Caution When Giving Cough and Cold Products to Kids

    Agency condition or prevention explanation

    FDA · Content/publication date: not stated
    Accessed: 2026-10-08 UTC · Selected relevant original official page passages inspected
    Cited sections: Ingredient duplication, ingredient-specific warnings and product labels

    Canonical redirect used; thresholds are not personal dosing advice.

  5. Antibiotics for the common cold and acute purulent rhinitis

    Published systematic review

    Cochrane review authors · Content/publication date: not stated
    Accessed: 2026-10-08 UTC · Original review summary and abstract passages inspected; no independent reanalysis
    Cited sections: No benefit, adverse effects, diagnostic flaws and displayed search methods

    Newer listing retains a displayed February 2013 search method.

  6. Key Information About OTC Oral Phenylephrine

    Agency medicine explanation

    FDA · Content/publication date: not stated
    Accessed: 2026-10-13 UTC · Indexed original abstract or official-page passages inspected in search; full-page access not established
    Cited sections: Efficacy-based proposed removal and oral-versus-nasal scope

    Selected-source explanation. Citation matching does not establish an independent evidence appraisal.

Scope & review

Population
General respiratory literacy; separate high-risk and pediatric contexts
Exposure or intervention
Viral illness, symptomatic products and antibiotic/placebo comparisons
Comparison
Source-specific test methods, placebo/usual care, or prevention settings
Outcomes
Symptoms, recovery, complications and medication adverse effects
Timeframe
Typical acute course and an older displayed review search
Jurisdiction
WHO global frameworks with selected US/UK explanations; eligibility and programs vary locally

Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-08 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
  • 2026-10-13 UTC: Deepened categories, applicability, uncertainty and competing interpretations using additional verified sources; prior anchors retained.

What this article still leaves open

  • A complete current symptom-treatment and supplement review, pathogen-specific distinctions and qualified review remain incomplete.
  • No individual diagnosis, antibiotic choice or pediatric medication dose is supplied.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.